Co-fluampicil

Co-fluampicil

Combination of
Ampicillin	Moderate-spectrum penicillin
Flucloxacillin	Antistaphylococcal penicillin
[[{{{component3}}}]]	? Class
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
Clinical data
Routes of administration	Oral, intravenous
ATC code	J01CR50 (WHO)
Identifiers
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

WikiDoc Resources for Co-fluampicil
Articles
Most recent articles on Co-fluampicil Most cited articles on Co-fluampicil Review articles on Co-fluampicil Articles on Co-fluampicil in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Co-fluampicil Images of Co-fluampicil Photos of Co-fluampicil Podcasts & MP3s on Co-fluampicil Videos on Co-fluampicil
Evidence Based Medicine
Cochrane Collaboration on Co-fluampicil Bandolier on Co-fluampicil TRIP on Co-fluampicil
Clinical Trials
Ongoing Trials on Co-fluampicil at Clinical Trials.gov Trial results on Co-fluampicil Clinical Trials on Co-fluampicil at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Co-fluampicil NICE Guidance on Co-fluampicil NHS PRODIGY Guidance FDA on Co-fluampicil CDC on Co-fluampicil
Books
Books on Co-fluampicil
News
Co-fluampicil in the news Be alerted to news on Co-fluampicil News trends on Co-fluampicil
Commentary
Blogs on Co-fluampicil
Definitions
Definitions of Co-fluampicil
Patient Resources / Community
Patient resources on Co-fluampicil Discussion groups on Co-fluampicil Patient Handouts on Co-fluampicil Directions to Hospitals Treating Co-fluampicil Risk calculators and risk factors for Co-fluampicil
Healthcare Provider Resources
Symptoms of Co-fluampicil Causes & Risk Factors for Co-fluampicil Diagnostic studies for Co-fluampicil Treatment of Co-fluampicil
Continuing Medical Education (CME)
CME Programs on Co-fluampicil
International
Co-fluampicil en Espanol Co-fluampicil en Francais
Business
Co-fluampicil in the Marketplace Patents on Co-fluampicil
Experimental / Informatics
List of terms related to Co-fluampicil

Co-fluampicil is the British Approved Name, for the combination of ampicillin and flucloxacillin β-lactam antibiotics (trade name Magnapen).

Indication

Ampicillin is a moderate spectrum penicillin antibiotic with good cover against Group A streptococcal infection whilst Flucloxacillin is a narrow spectrum antibiotic with cover against Staphylococcus aureus. The combination covers the two most likely bacteria in cellulitis infections in the arm or leg.

Formulations

As Co-fluampicil 250/250 capsules containing 250mg of each component, Co-fluampicil 125/125 syrup or as Co-fluampicil 250/250 powder for reconstruction for intravenous injection.

Dosage

Typical oral dosage is Co-fluampicil 250/250 four times a day, doubled in severe infection and half the dose for children under 10 years.

Side-effects

As per the individual components with stomach or bowel upset from the Flucloxacillin being the most common. Both parts are members of the penicillin family of antibiotics, and therefore should not be taken by patients allergic to penicillin. See Flucloxacillin for additional contraindications.

References

• British National Formulary '50' September 2005

Template:WS